GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » EV-to-EBIT

Tsubota Laboratory (TSE:4890) EV-to-EBIT : -11.91 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tsubota Laboratory EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tsubota Laboratory's Enterprise Value is 円7,569.3 Mil. Tsubota Laboratory's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円-635.4 Mil. Therefore, Tsubota Laboratory's EV-to-EBIT for today is -11.91.

The historical rank and industry rank for Tsubota Laboratory's EV-to-EBIT or its related term are showing as below:

TSE:4890' s EV-to-EBIT Range Over the Past 10 Years
Min: -209.4   Med: 93.27   Max: 1542.95
Current: -11.91

During the past 5 years, the highest EV-to-EBIT of Tsubota Laboratory was 1542.95. The lowest was -209.40. And the median was 93.27.

TSE:4890's EV-to-EBIT is ranked worse than
100% of 451 companies
in the Medical Devices & Instruments industry
Industry Median: 19.7 vs TSE:4890: -11.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tsubota Laboratory's Enterprise Value for the quarter that ended in Dec. 2023 was 円7,182.4 Mil. Tsubota Laboratory's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円-635.4 Mil. Tsubota Laboratory's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -8.85%.


Tsubota Laboratory EV-to-EBIT Historical Data

The historical data trend for Tsubota Laboratory's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsubota Laboratory EV-to-EBIT Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
- - - 130.74 -11.47

Tsubota Laboratory Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.74 275.76 -31.71 -6.55 -

Competitive Comparison of Tsubota Laboratory's EV-to-EBIT

For the Medical Devices subindustry, Tsubota Laboratory's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsubota Laboratory's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tsubota Laboratory's EV-to-EBIT falls into.



Tsubota Laboratory EV-to-EBIT Calculation

Tsubota Laboratory's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7569.288/-635.366
=-11.91

Tsubota Laboratory's current Enterprise Value is 円7,569.3 Mil.
Tsubota Laboratory's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-635.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tsubota Laboratory  (TSE:4890) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tsubota Laboratory's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-635.366/7182.4355
=-8.85 %

Tsubota Laboratory's Enterprise Value for the quarter that ended in Dec. 2023 was 円7,182.4 Mil.
Tsubota Laboratory's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-635.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tsubota Laboratory EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tsubota Laboratory's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsubota Laboratory (TSE:4890) Business Description

Traded in Other Exchanges
N/A
Address
34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

Tsubota Laboratory (TSE:4890) Headlines

No Headlines